FdaApplication
ANDA 206198
Identifiers
- fda_app_no: ANDA206198
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2020-07-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE;INJECTION |
| OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION |
2 products